Therefore, a high level of IDO expression may precede a favorable shift in Th1/Th2-mediated immune responses in chronic inflammatory diseases such as MS, and measurement of IDO gene expression and activity in the blood is being explored as a useful biomarker to monitor the course of relapsing-remiting MS [117,118]. The gene discussed is IDO1; the disease is myeloid sarcoma.